Recent Finacing
Recent Raise
Elucid provides interpretable, FDA-cleared AI software (PlaqueIQ/ElucidVivo) that noninvasively analyzes CTA to quantify and characterize arterial plaque validated against histopathology, derive FFRct, and inform cardiovascular treatment decisions.
